Thermo Fisher Scientific | TMO - Srodki Pieniężne I Ekwiwalent

Cena Akcji
496.11
Dzienna Zmiana
-4.35 -0.87%
Miesięcznie
0.08%
Rocznie
13.23%
Q2 Prognozy TE
482.57




Srodki Pieniężne I Ekwiwalent Zmiana Data
Abbott USD 8.52B 1.01B 2025-12
Agilent USD 1.76B 31M 2025-12
Becton, Dickinson and Co. USD 740M 99M 2025-12
Bio Techne USD 172.88M 27.92M 2025-12
Bio-Rad Laboratories USD 529.8M 134M 2025-12
Boston Scientific USD 1.96B 690M 2025-12
Bruker USD 293.1M 201.1M 2025-09
Charles River Laboratories USD 213.77M 6.67M 2025-12
Danaher USD 4.62B 3.09B 2025-12
Dentsply International USD 326M 37M 2025-12
Edwards Lifesciences USD 2.69B 587.2M 2025-09
General Electric Aerospace USD 12.39B 109M 2025-12
Henry Schein USD 136M 9M 2025-09
Hologic USD 2.17B 208.5M 2025-12
Illumina USD 1.42B 368M 2025-12
Intuitive Surgical USD 9.03B 601.6M 2025-12
IQVIA Holdings USD 1.98B 166M 2025-12
Laboratory Of America USD 532.3M 65.8M 2025-12
Medtronic USD 1.15B 135M 2025-12
Mettler Toledo International USD 69.06M 7.24M 2025-09
Myriad Genetics USD 149.6M 4.2M 2025-12
Olympus JPY 147.24B 93.98B 2025-09
OraSure Technologies USD 199.28M 17.2M 2025-12
Quest Diagnostics USD 420M 12M 2025-12
Repligen USD 566.02M 182.73M 2025-12
Revvity USD 919.86M 11.53M 2025-12
Stryker USD 4.01B 755M 2025-12
Thermo Fisher Scientific USD 9.85B 7.87B 2025-12
Veracyte USD 362.58M 47M 2025-12
Waters USD 587.83M 128.71M 2025-12
Zimmer Biomet Holdings USD 591.9M 700.8M 2025-12